Could adding ketamine to a standard pain block ease hysterectomy recovery?
NCT ID NCT07482709
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding ketamine to a standard abdominal pain block (TAP block) reduces pain after total abdominal hysterectomy better than the block alone. Thirty women aged 25–60 will be randomly assigned to receive either bupivacaine alone or bupivacaine plus ketamine. Pain levels and the need for extra pain medication will be tracked for 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine with ketamine
- What this could lead to
- If it works, this could offer better pain control after hysterectomy and reduce the need for extra painkillers.
- What could go wrong
- This is a small, early-phase trial with only 30 participants, so results may not apply widely. Adding ketamine could also cause side effects like dizziness or nausea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged between 25 to 60 years. * ASA grade I \& II. * Undergoing total abdominal hysterectomy. Exclusion Criteria: * BMI \>35kg/m2. * Patient refusal for participation. * Patients with coagulation disorders. * Patents with history of allergy and hypersensitivity to local anesthetic. * Patient having infection at the injection site. * Alcohol or drug abuse. * Cognitive or mental disorder.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Post operative pain in total abdominal hystrectomy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
gynae operation theatre at Liaquat National Hospital
RECRUITINGKarachi, Sindh, 74800, Pakistan
Contact Email: •••••@•••••